TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma

WITHDRAWN

Identifier: CI-TRIAL-00046156
Entity page: /trial/NCT03506802 ↗
Edges: 7

Neighbours: 1 cancers5 drugs
Drawn: 6 of 6 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma condition of …CONDITION_OFderived2 of 2
← condition of	Multiple Myeloma registry condition “Recurrent Plasma Cell Myeloma” mapped CURATED_BROADER	—	—	Multiple Myeloma	1	Observed	clinicaltrials	graph →
← condition of	Multiple Myeloma registry condition “Refractory Plasma Cell Myeloma” mapped CURATED_BROADER	—

TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma intervention of …INTERVENTION_OFderived5 of 5
← intervention of	Aldesleukinother registry intervention “Aldesleukin” (BIOLOGICAL) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Filgrastimother registry intervention “Filgrastim” (BIOLOGICAL) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Lenalidomidesmall molecule registry intervention “Lenalidomide” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Melphalansmall molecule registry intervention “Melphalan” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Plerixaforsmall molecule registry intervention “Plerixafor” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma intervention of …INTERVENTION_OFderived5 of 5

← intervention of

Aldesleukinother

registry intervention “Aldesleukin” (BIOLOGICAL) mapped ALIAS

—

not mapped

Observed

clinicaltrials

graph →

← intervention of

Filgrastimother

registry intervention “Filgrastim” (BIOLOGICAL) mapped ALIAS

—